Table 1 Demographic characteristics of the study groups
Study Group SARS-CoV-2 (+) (n = 30) | Control Group SARS-CoV-2 (-) (n = 60) | P | |
|---|---|---|---|
GA (week) mean ± SDS | 38.16 ± 0.98 | 38.16 ± 0.97 | 1.00 |
BW (g) mean ± SDS | 3167 ± 390 | 3168 ± 302 | 0.98 |
Gender (Boy) n (%) | 14 (46.6) | 36 (60) | 0.26 |
Delivery n (%) Vaginal Cesarean | 8 (26.6) | 38 (63.3) | 0.002 |
22 (73.4) | 22 (36.7) | 0.002 | |
Prenatal history n (%) Preeclampsia GDM | 1 (3.3) | 4 (6.6) | 0.66 |
1 (3.3) | 2 (3.3) | 1.00 | |
Maternal age (years) n (%) 15–25 25–35 >35 | 13 (43.3) 10 (33.3) 7 (23.3) | 23 (38.3) 23 (38.3) 14 (23.3) | 0.87 |
Maternal education n (%) Haven’t any education Elementery education High school University/postgraduate | 5 (16.6) 11 (36.6) 9 (30) 5 (16.6) | 9 (15) 23 (38.3) 17 (28.3) 11 (18.3) | 0.99 |
APGAR score 5 (≥ 7) n (%) | 30 (100) | 60 (100) | NS |
Fever ≥ 38 °C n (%) | 14 (46.6) | 16 (26.6) | 0.44 |
Respiratory status n (%) Supplemental O2 Noninvasive respiratory support | 4 (13.3) 3 (10) | 3 (5) 6 (10) | 0.37 |
Respiratory support (hour) mean ± SDS | 34.85 ± 21.75 | 28.22 ± 13.20 | 0.46 |
Bayley II Scale age (month) mean ± SDS | 20.50 ± 2.46 | 21.10 ± 2.46 | 0.30 |